A detailed history of Windward Capital Management CO transactions in Pfizer Inc stock. As of the latest transaction made, Windward Capital Management CO holds 77,089 shares of PFE stock, worth $2.05 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
77,089
Previous 75,931 1.53%
Holding current value
$2.05 Million
Previous $2.12 Million 4.99%
% of portfolio
0.18%
Previous 0.19%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$27.7 - $31.39 $32,076 - $36,349
1,158 Added 1.53%
77,089 $2.23 Million
Q2 2024

Aug 06, 2024

SELL
$25.26 - $29.6 $67,065 - $78,588
-2,655 Reduced 3.38%
75,931 $2.12 Million
Q1 2024

Sep 20, 2024

BUY
$25.89 - $29.73 $68,712 - $78,903
2,654 Added 3.5%
78,585 $2.18 Million
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $9,527 - $10,940
-368 Reduced 0.47%
78,586 $2.18 Million
Q4 2023

Oct 03, 2024

BUY
$26.13 - $33.94 $13,848 - $17,988
530 Added 0.68%
78,954 $2.27 Million
Q4 2023

Jan 16, 2024

BUY
$26.13 - $33.94 $13,848 - $17,988
530 Added 0.68%
78,954 $2.27 Million
Q3 2023

Oct 03, 2024

BUY
$32.09 - $37.51 $80,000 - $93,512
2,493 Added 3.28%
78,424 $2.6 Million
Q3 2023

Oct 20, 2023

SELL
$32.09 - $37.51 $6,931 - $8,102
-216 Reduced 0.27%
78,424 $2.6 Million
Q2 2023

Jul 18, 2023

SELL
$36.12 - $41.79 $1,842 - $2,131
-51 Reduced 0.06%
78,640 $2.89 Million
Q1 2023

Apr 24, 2023

SELL
$39.39 - $51.28 $8,823 - $11,486
-224 Reduced 0.28%
78,691 $3.21 Million
Q3 2022

Oct 14, 2022

BUY
$43.76 - $53.42 $24,111 - $29,434
551 Added 0.7%
78,915 $3.45 Million
Q2 2022

Jul 08, 2022

BUY
$46.53 - $55.17 $23,032 - $27,309
495 Added 0.64%
78,364 $4.11 Million
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $42,090 - $52,154
-920 Reduced 1.17%
77,869 $4.03 Million
Q4 2021

Jan 14, 2022

BUY
$41.32 - $61.25 $41,196 - $61,066
997 Added 1.28%
78,789 $4.65 Million
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $12,560 - $16,134
320 Added 0.41%
77,792 $3.35 Million
Q2 2021

Jul 19, 2021

BUY
$35.91 - $40.68 $18,601 - $21,072
518 Added 0.67%
77,472 $3.03 Million
Q1 2021

Apr 15, 2021

SELL
$33.49 - $37.77 $13.8 Million - $15.5 Million
-411,675 Reduced 84.25%
76,954 $2.79 Million
Q4 2020

Jan 21, 2021

SELL
$33.47 - $42.56 $2.41 Million - $3.06 Million
-71,997 Reduced 12.84%
488,629 $18 Million
Q3 2020

Oct 13, 2020

SELL
$31.75 - $37.25 $154,305 - $181,035
-4,860 Reduced 0.86%
560,626 $20.6 Million
Q2 2020

Jul 20, 2020

SELL
$30.12 - $36.54 $183,430 - $222,528
-6,090 Reduced 1.07%
565,486 $18.5 Million
Q1 2020

Apr 14, 2020

SELL
$27.03 - $38.62 $478,701 - $683,960
-17,710 Reduced 3.01%
571,576 $18.7 Million
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $486,491 - $552,106
14,778 Added 2.57%
589,286 $23.1 Million
Q3 2019

Oct 15, 2019

BUY
$32.49 - $42.13 $237,761 - $308,307
7,318 Added 1.29%
574,508 $20.6 Million
Q2 2019

Jul 11, 2019

SELL
$36.98 - $41.52 $283,784 - $318,624
-7,674 Reduced 1.33%
567,190 $24.6 Million
Q1 2019

Apr 12, 2019

BUY
$37.5 - $41.2 $140,625 - $154,500
3,750 Added 0.66%
574,864 $24.4 Million
Q4 2018

Jan 15, 2019

BUY
$38.47 - $43.86 $242,553 - $276,537
6,305 Added 1.12%
571,114 $24.9 Million
Q3 2018

Oct 10, 2018

BUY
$34.47 - $41.81 $2,206 - $2,675
64 Added 0.01%
564,809 $24.9 Million
Q2 2018

Jul 12, 2018

SELL
$32.98 - $35.16 $20,480 - $21,834
-621 Reduced 0.11%
564,745 $20.5 Million
Q1 2018

Apr 12, 2018

BUY
$31.91 - $37.02 $564,073 - $654,402
17,677 Added 3.23%
565,366 $20.1 Million
Q4 2017

Jan 11, 2018

BUY
$33.26 - $35.29 $338,021 - $358,652
10,163 Added 1.89%
547,689 $19.8 Million
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $16.7 Million - $18.4 Million
537,526
537,526 $19.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Windward Capital Management CO Portfolio

Follow Windward Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windward Capital Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Windward Capital Management CO with notifications on news.